Seòmar agus comataidhean

After suffering a substantial cyberattack in December 2020, SEPA enacted business continuity arrangements and implemented procedures to ensure priority planning and business critical cases were responded to.

SEPA worked with planning authorities and other consulting bodies, providing practical planning advice. By August 2021, SEPA had processed the backlog of cases and to date have responded to 1597 consultations.

Estimated spend on dementia by each Integration Joint Board in each year since 2016 is as follows:-

Our clear ambition is that no one should be inappropriately delayed in hospital once they are clinically ready for discharge. However, given the current challenges health and social care partnerships are experiencing in relation to recruitment of care staff, and the increased level of needs people are presenting with, we need to set a realistic trajectory for reduction. Our intention is therefore to see a return to the position seen between the Summer of 2020 and Spring of 2021, freeing up at least 500 beds for winter.

We listened closely to small retailers in designing Scotland’s Deposit Return Scheme (DRS). Under the DRS Regulations, return-point operators including small retailers will be able to claim a reasonable handling fee from the DRS scheme administrator for each container returned. This fee must cover costs including the rental value of space used to collect or store scheme packaging and will ensure small retailers are not out of pocket for operating a return point.

Retailers will also be able to refuse returns where the quantity of material is disproportionately greater than the volume of containers they would usually sell as part of a single transaction.

We are confident that these protections will ensure that small retailers can successfully operate a return point. Nevertheless, the DRS Regulations do allow a retailer to apply to the Scottish Ministers for an exemption from the obligation to operate a return point where they meet certain criteria. Further information is available at: https://depositreturnscheme.zerowastescotland.org.uk/ .

I have asked Teresa Medhurst, Interim Chief Executive of the Scottish Prison Service (SPS), to respond. Her response is as follows:

The SPS awarded the pre-construction services contract for the HMP Highland project to Balfour Beatty in September 2021.

The SPS are working with Balfour Beatty to further develop the design of HMP Highland, prior to the award of a stage two contract that will deliver the construction element of the project.

Our 2018 Guidance on Due Diligence: Human Rights sets out how the Scottish Government, our executive agencies and non-departmental public bodies should undertake appropriate due diligence on companies, including their human rights record, before entering into an investment relationship with them. Building on this, Scottish Enterprise’s Customer Due Diligence Procedure, introduced in 2019, sets out the process that it follows to undertake human rights due diligence checks on companies it works with. Such checks are based on a rigorous process and independent evidence. Scottish Enterprise is confident that it has acted in full accordance with this Procedure.

The Scottish Government supports implementation of the UN Guiding Principles on Business and Human Rights and agrees with others in the international community that Israeli settlements are illegal under international law; making it harder for a peaceful two state solution to be reached.

In 2018, the Scottish Government published Guidance on Due Diligence: Human Rights [1] , setting out how we, our executive agencies and non-departmental public bodies should undertake appropriate due diligence on companies, including their human rights record, before entering into an investment relationship with them. This list of 112 companies identified by the UN Human Rights Office as being involved in activities related to illegal Israeli settlements in occupied Palestine, during the period from 1 January 2018 to 1 August 2019, is one piece of information to be considered in that due diligence process.

Existing policy guidance on procurement outlines actions that public bodies can take if they believe there are grounds to exclude companies active in any illegal settlements from bidding for public contracts [2] .

I have asked officials to write to the Chief Executives of relevant public bodies to remind them of the policy guidance, make them aware of this UN list and ask them to provide information to officials on any relationships they have with companies on this list. Following this, I will write to any companies, thus identified, seeking an update on their activities in the Occupied Palestinian Territories and what they are doing to cease those specific activities- as identified by the independent international fact-finding mission, which provided the basis for their inclusion in this list.

On account management services or other support, as noted in response to question S6W-00182, Scottish Enterprise is confident that it has acted in full accordance with their internal due diligence procedure, introduced in 2019. This procedure follows from the 2018 Scottish Government guidance.

As policies and procedures on due diligence and procurement are updated the Scottish Government takes account of the latest findings and recommendations of international bodies such as the UN.

All answers to written Parliamentary Questions are available on the Parliament's website, the search facility for which can be found at https://www.parliament.scot/chamber-and-committees/written-questions-and-answers

[1] https://www.gov.scot/publications/due-diligence-checks-good-practice-guidance/

[2] https://www.webarchive.org.uk/wayback/archive/20160106214501/http:/www.gov.scot/Topics/Government/Procurement/policy/SPPNSSPANS/policy-notes/SPPN2014/SPPN42014

The Scottish Government supports implementation of the UN Guiding Principles on Business and Human Rights and agrees with others in the international community that Israeli settlements are illegal under international law; making it harder for a peaceful two state solution to be reached.

In 2018, the Scottish Government published Guidance on Due Diligence: Human Rights [1] , setting out how we, our executive agencies and non-departmental public bodies should undertake appropriate due diligence on companies, including their human rights record, before entering into an investment relationship with them. This list of 112 companies identified by the UN Human Rights Office as being involved in activities related to illegal Israeli settlements in occupied Palestine, during the period from 1 January 2018 to 1 August 2019, is one piece of information to be considered in that due diligence process.

Existing policy guidance on procurement outlines actions that public bodies can take if they believe there are grounds to exclude companies active in any illegal settlements from bidding for public contracts [2] .

I have asked officials to write to the Chief Executives of relevant public bodies to remind them of the policy guidance, make them aware of this UN list and ask them to provide information to officials on any relationships they have with companies on this list. Following this, I will write to any companies, thus identified, seeking an update on their activities in the Occupied Palestinian Territories and what they are doing to cease those specific activities- as identified by the independent international fact-finding mission, which provided the basis for their inclusion in this list.

On account management services or other support, as noted in response to question S6W-00182 on 27 October 2021, Scottish Enterprise is confident that it has acted in full accordance with their internal due diligence procedure, introduced in 2019. This procedure follows from the 2018 Scottish Government guidance.

As policies and procedures on due diligence and procurement are updated the Scottish Government takes account of the latest findings and recommendations of international bodies such as the UN.

All answers to written Parliamentary Questions are available on the Parliament's website, the search facility for which can be found at https://www.parliament.scot/chamber-and-committees/written-questions-and-answers

[1] https://www.gov.scot/publications/due-diligence-checks-good-practice-guidance/

[2] https://www.webarchive.org.uk/wayback/archive/20160106214501/http:/www.gov.scot/Topics/Government/Procurement/policy/SPPNSSPANS/policy-notes/SPPN2014/SPPN42014

As announced by HM Treasury on 14 November 2016, the Scottish Government's population-based settlement from the UK Government's Apprenticeship Levy was £221 million in 2017-18, £230 million in 2018-19 and £239 million in 2019-20. This funding was allocated as part of the block grant.

From 2020-21 there has been no notional allocation of Apprenticeship Levy revenue included in the block grant and the normal operation of the Barnett Formula has provided a similar outcome. The UK Government collects the Levy and has details on who is liable to pay it and what revenue is accrued, with the Scottish Government not being responsible for this information.

Future allocations from the Apprenticeship Levy will be received as part of the block grant, and we have no advance notice of what this will be.

The National Services Division (NSD) in NHS National Services Scotland (NSS) have commissioning responsibility for the Scottish Genetic Laboratories. NSD are currently conducting a review of NHS Scotland’s genomic services which includes a review of the Scottish genomic test directory and genomics infrastructure. The review is expected to be completed by the end of the 2021-2022 financial year.

The outcomes from the review will be considered by the Scottish Genomics Leadership Group (SGLG), chaired jointly by Professor David Crossman, Chief Scientist for Health for the Scottish Government, and Susan Buchanan, NSD Director, who are supporting the Scottish Government in ensuring appropriate planning and robust decision-making processes are in place for genetic testing availability in Scotland.

In addition, the SGLG and NSD are working closely with the Scottish Genetics Laboratory Consortium and the Scottish Medicines Consortium to understand the laboratory capacity requirements for current and future medicines requiring a companion diagnostic test.